Inclusion Criteria:

- Patient treated at the outpatient clinic or admitted to the oncology unit of
Notre-Dame Hospital between February 4, 2013 and July 19, 2013;

- Patient diagnosed with cancer;

- Patient starting a chemotherapy containing paclitaxel every two to three weeks for a
minimum of two cycles;

- Patient aged 18 years and over;

- Patient able to give free and informed consent and who agrees to participate by
signing the consent form;

- Patient able to complete the questionnaire on quality of life EORTC QLQ-C30 and the
personal logbook.

Exclusion Criteria:

- Patient unable to speak English or French;

- Patient who has previously received paclitaxel;

- Patient receiving a prescription of paclitaxel bound to albumin;

- Patient is currently under treatment with systemic corticosteroids or has received
systemic corticosteroids during the last week;

- Patient in another research protocol evaluating a different chemotherapy regimen;

- Patient who had an allergic reaction to taxanes;

- Patient with severe intolerance to lactose;

- Patient with an allergy or a severe intolerance to products containing castor oil
(eg.: cyclosporine and vitamin K).